Table 3:
Results of index values.
| GADA-Index | COVID-19A-Index | IA-2A-Index | TGA-Index | ZnT8A-Index | IAA-Index | |
|---|---|---|---|---|---|---|
| GADA high PC | 1.000 | 1.0 | 0.000 | 0.001 | 0.004 | 0.001 |
| GADA low PC | 0.285 | 0.4 | 0.004 | 0.002 | 0.001 | 0.003 |
| COVID-19A high PC | 0.001 | 100.0 | 0.001 | 0.002 | −0.001 | −0.001 |
| COVID-19A low PC | 0.014 | 10.6 | −0.001 | 0.001 | 0.000 | 0.000 |
| IA-2A/ZnT8A PC | 0.009 | −0.3 | 1.000 | 0.003 | 1.000 | 0.001 |
| TGA PC | 0.018 | 0.0 | 0.003 | 1.000 | −0.001 | 0.001 |
| IAA high PC | 0.002 | 0.1 | −0.002 | 0.000 | 0.003 | 1.000 |
| IAA low PC | 0.002 | −0.2 | 0.001 | 0.002 | 0.005 | 0.023 |
| NC | 0.000 | 0.0 | 0.000 | 0.000 | 0.000 | 0.000 |
| sample1 | 0.424 | 0.0 | −0.003 | 0.000 | 0.001 | −0.002 |
| sample2 | −0.001 | 0.0 | 0.109 | 0.001 | 0.000 | 0.000 |
| sample3 | 0.000 | 0.0 | −0.002 | 1.355 | −0.001 | −0.001 |
| sample4 | −0.001 | 324.2 | 0.000 | 0.000 | 0.000 | −0.001 |
| sample5 | 0.001 | −0.2 | 0.001 | 0.000 | 0.586 | −0.001 |
| sample6 | −0.001 | −0.2 | −0.002 | 0.000 | 0.000 | 0.026 |
| sample7 | 0.066 | −0.2 | 0.224 | 0.000 | 0.010 | 0.032 |
| sample8 | −0.002 | 0.0 | −0.004 | 0.001 | −0.001 | 0.001 |
| sample9 | −0.001 | 0.0 | −0.001 | 0.089 | −0.001 | 0.038 |
| sample10 | −0.001 | −0.1 | −0.003 | −0.001 | 0.000 | 0.001 |
| sample11 | 0.003 | 0.1 | 0.105 | 0.000 | 0.000 | 0.000 |
| sample12 | 0.001 | 0.0 | −0.003 | 0.000 | 0.000 | 0.001 |
| sample13 | −0.002 | 202.5 | 0.001 | 0.000 | −0.001 | 0.001 |
| sample14 | 0.059 | 493.6 | −0.002 | 0.000 | −0.001 | −0.001 |
| sample15 | −0.001 | −0.2 | −0.001 | 0.003 | −0.002 | 0.000 |
Index values for each sample for all six antibodies were calculated against the corresponding positive and negative controls. An index value greater than the cutoff value was defined as positive, marked in dark bold. The bad duplicate CPS values in Table 1, row Dlinker 3-columns 5 and 6, led to a positive IA-2A index value of sample 11 (highlighted in grey), which was probably a falsepositive result.